You are using a browser that is not supported by this site. The site will not function properly. Please switch to the latest version of a supported browser such as Chrome, Safari, Edge, or Firefox to use this site.
RemunityPRO™
INTRODUCING THE NEXT-GENERATION PUMP FOR PAH
Your partner in Remodulin therapy, the RemunityPRO pump was thoughtfully designed with patient feedback. Watch the video to learn more.
RemunityPRO™ for Remodulin: Innovation that delivers
RemunityPRO is thoughtfully designed for people living with PAH. It delivers advanced technology and features that help make starting and staying on Remodulin less complicated. RemunityPRO fits into your personal routine with:
- A small, discreet pump that fits in a pocket or purse
- Continuous delivery of Remodulin under the skin
- Patients currently on the first generation of Remunity pump are not required to transition to the RemunityPRO pump
Optimized features include:
- A user-friendly remote with step-by-step instructions
- Automated priming
- Simplified filling
- Mindful alerts
- Advanced Bluetooth® connectivity
CONVENIENCE
Compact and lightweight at 2” in diameter, 3/4” thick, and 1.7 ounces, RemunityPRO fits easily on a belt or in a pocket. Easy to learn, easy to fill, and self-priming, it delivers 72 hours of medication for peace of mind.
CONFIDENCE
Adjusting to pump therapy can take time, but RemunityPRO—designed with feedback from patients with PAH—makes it more simple. It features optimized Bluetooth®, a redesigned remote with guided instructions, streamlined alerts, and more to help you feel confident and supported.
CARE AND SUPPORT
You’ll have a team of experts and a range of resources dedicated to supporting you and making sure you have what you need, when you need it. Throughout your journey, RemunityPRO helps you focus on what matters most—living your life, your way.
Getting started with RemunityPRO
Before you start, familiarize yourself with the features that RemunityPRO offers and learn how to use this beginner-friendly pump. Check out these helpful resources:
RemunityPRO Training Videos: Get step-by-step instructions for every aspect of your pump.
Watch the videos
RemunityPRO Brochure: A must-have resource full of information on getting started.
Download the Brochure
Meet MYREMODULIN.COM
- For people about to start or currently on therapy, MyRemodulin.com is a personalized website experience available from day one. It offers information specific to your therapy’s route of administration, your pump, and your journey
- You’ll have access to pump user guides, encouraging videos, helpful tips for an improved experience, and much more
Interested in learning more about RemunityPRO?
The RemunityPRO User Guide takes you through everything you need to know when starting or transitioning to RemunityPRO.
Get Connected!
Remodulin has an active social community on Facebook, Instagram, and YouTube.
Join these platforms to connect with other people with PAH.
Click an icon to visit us on social:
What you need, when you need it most.
United Therapeutics Cares provides you with ongoing, one-on-one education and support beginning on day one of your United Therapeutics treatment journey.
Your dedicated Patient Navigator will personalize support and answer questions about what to expect as you begin treatment, including insurance coverage, out-of-pocket cost assistance, co-pay assistance, and prescription fulfillment.
Visit United Therapeutics cares
Sign up to get support emails
Become a member of the Remodulin Support Program to get helpful tips, resources, and more delivered straight to your inbox.
For Important Safety Information on RemunityPRO, please click here.
Remodulin® (treprostinil) Injection
Important Safety Information for Remodulin
Before you take Remodulin, tell your healthcare provider if you:
- Have other medical conditions or take other medicines that may affect your use of Remodulin by increasing the risk of side effects or decreasing the drug’s effectiveness.
- Have liver problems. Your Remodulin dose may need to be adjusted if you have liver problems.
- Have low blood pressure or bleeding problems.
- Are taking gemfibrozil (for high cholesterol), rifampin (for infection) or other drugs that affect liver enzymes. Your doctor may need to adjust your Remodulin dosage.
- Are pregnant, breastfeeding, or planning to become pregnant. It is not known if Remodulin will harm your unborn baby or if Remodulin passes into your breast milk.
What are the serious side effects of Remodulin?
- Continuous intravenous (IV) infusions of Remodulin delivered using an external infusion pump, with a tube placed in a central vein within the chest, are associated with the risk of blood stream infections and sepsis, which may be fatal. Therefore, continuous subcutaneous (SC) infusion delivered just beneath the skin is the preferred type of delivery.
- Worsening of PAH symptoms. Do not stop taking or greatly reduce your Remodulin dose without consulting your doctor.
- Low blood pressure (symptomatic hypotension). If you have low blood pressure or are taking drugs that lower your blood pressure, the risk of low blood pressure is increased.
- Bleeding problems. Remodulin may increase the risk of bleeding in people who take blood thinners (anticoagulants).
What are the possible side effects of Remodulin?
- In clinical studies of SC infusion of Remodulin, most people experienced infusion site pain and infusion site reaction (redness, swelling, and rash). These symptoms were sometimes severe and sometimes required treatment with narcotics or discontinuation of Remodulin.
- IV infusion of Remodulin delivered through an external pump has been associated with the risk of blood stream infections, arm swelling, tingling sensations, bruising, and pain.
- The most common side effects seen with either SC or IV Remodulin were headache, diarrhea, nausea, rash, jaw pain, widening of the blood vessels (vasodilatation), and swelling from fluid retention (edema). These are not all the possible side effects of Remodulin. Call your doctor for medical advice about side effects.
You may report side effects to the FDA at www.fda.gov/MedWatch or call 1-800-FDA-1088.
You may report side effects to the FDA at www.fda.gov/MedWatch or call 1-800-FDA-1088.
What is Remodulin?
Remodulin is a prescription medication used to treat adults with pulmonary arterial hypertension (PAH; WHO Group 1), which is high blood pressure in the arteries of your lungs. Remodulin can reduce symptoms associated with exercise. Remodulin was studied mainly in patients with NYHA Functional Class II-IV symptoms. It is not known if Remodulin is safe and effective in children.
In people with PAH who need to switch from epoprostenol, Remodulin is approved to slow the worsening of symptoms.
The risk information provided here is not comprehensive. To learn more about Remodulin, talk with your healthcare provider. Please see Full Prescribing Information at www.remodulin.com or call Customer Service at 1-844-UNITHER (1-844-864-8437).
To learn more about Remodulin, talk with your healthcare provider. Please see Full Prescribing Information at www.remodulin.com or call Customer Service at 1-844-UNITHER (1-844-864-8437).
REMISIconFEB2025
PAH=pulmonary arterial hypertension; WHO=World Health Organization.
Remodulin® (treprostinil) Injection
Important Safety Information for Remodulin
Before you take Remodulin, tell your healthcare provider if you:
- Have other medical conditions or take other medicines that may affect your use of Remodulin by increasing the risk of side effects or decreasing the drug’s effectiveness.
- Have liver problems. Your Remodulin dose may need to be adjusted if you have liver problems.
- Have low blood pressure or bleeding problems.
- Are taking gemfibrozil (for high cholesterol), rifampin (for infection) or other drugs that affect liver enzymes. Your doctor may need to adjust your Remodulin dosage.
- Are pregnant, breastfeeding, or planning to become pregnant. It is not known if Remodulin will harm your unborn baby or if Remodulin passes into your breast milk.
What are the serious side effects of Remodulin?
- Continuous intravenous (IV) infusions of Remodulin delivered using an external infusion pump, with a tube placed in a central vein within the chest, are associated with the risk of blood stream infections and sepsis, which may be fatal. Therefore, continuous subcutaneous (SC) infusion delivered just beneath the skin is the preferred type of delivery.
- Worsening of PAH symptoms. Do not stop taking or greatly reduce your Remodulin dose without consulting your doctor.
- Low blood pressure (symptomatic hypotension). If you have low blood pressure or are taking drugs that lower your blood pressure, the risk of low blood pressure is increased.
- Bleeding problems. Remodulin may increase the risk of bleeding in people who take blood thinners (anticoagulants).
What are the possible side effects of Remodulin?
- In clinical studies of SC infusion of Remodulin, most people experienced infusion site pain and infusion site reaction (redness, swelling, and rash). These symptoms were sometimes severe and sometimes required treatment with narcotics or discontinuation of Remodulin.
- IV infusion of Remodulin delivered through an external pump has been associated with the risk of blood stream infections, arm swelling, tingling sensations, bruising, and pain.
- The most common side effects seen with either SC or IV Remodulin were headache, diarrhea, nausea, rash, jaw pain, widening of the blood vessels (vasodilatation), and swelling from fluid retention (edema). These are not all the possible side effects of Remodulin. Call your doctor for medical advice about side effects.
You may report side effects to the FDA at www.fda.gov/MedWatch or call 1-800-FDA-1088.
What is Remodulin?
Remodulin is a prescription medication used to treat adults with pulmonary arterial hypertension (PAH; WHO Group 1), which is high blood pressure in the arteries of your lungs. Remodulin can reduce symptoms associated with exercise. Remodulin was studied mainly in patients with NYHA Functional Class II-IV symptoms. It is not known if Remodulin is safe and effective in children.
In people with PAH who need to switch from epoprostenol, Remodulin is approved to slow the worsening of symptoms.
The risk information provided here is not comprehensive. To learn more about Remodulin, talk with your healthcare provider. Please see Full Prescribing Information at www.remodulin.com or call Customer Service at 1-844-UNITHER (1-844-864-8437).
REMISIconFEB2025
PAH=pulmonary arterial hypertension; WHO=World Health Organization.